Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term persistence and booster of Nimenrix in children
NCT00718666Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2008
- Primary completion
- Nov 2013
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of meningococcal group A, C, W135 and Y conjugate vaccine in meningococcal infection, sponsored by GSK. Started Oct 2008; status: completed.
02
Drugs
meningococcal group A, C, W135 and Y conjugate vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT00718666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00718666.